Innovations In Personal Genome Services Enhance Risk Prediction And Preventive Care In Prostate Cancer Is Playing A Role In Shaping The Personal Genome Services Market

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Forecasted Market Size Trajectory Of The Personal Genome Services Market From 2026 To 2030?

The personal genome services market has seen substantial expansion over recent years. It is projected to increase from $6.84 billion in 2025 to $7.85 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 14.7%. This historical growth can be attributed to factors such as reduced sequencing costs, a rise in demand for ancestry testing, enhanced consumer awareness of genetics, the expansion of genomics startups, and improved sequencing accuracy.

The personal genome services market is projected for swift expansion in the upcoming years. By 2030, its size is anticipated to reach $13.69 billion, expanding at a compound annual growth rate (CAGR) of 14.9%. This projected growth during the forecast period stems from factors such as increasing adoption of preventive genomics, wider application of pharmacogenomics, growing demand for personalized wellness solutions, more extensive insurance coverage for testing, and the integration with digital health platforms. Key trends expected during the forecast period encompass direct-to-consumer genome testing, integrated genomic reports for health risks, bundled pharmacogenomic services, preventive genome screening packages, and digital platforms for genetic counseling.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=33258&type=smp

What Leading Drivers Are Supporting The Personal Genome Services Market Expansion?

A growing emphasis on personalized medicine is anticipated to fuel the expansion of the personal genome services market in the future. This medical approach involves tailoring treatment and prevention plans specifically to an individual’s unique genetic, biological, and lifestyle attributes. Its adoption is on the rise, driven by breakthroughs in genomics and molecular diagnostics that enable treatments to be customized according to a person’s genetic profile, leading to improved results. Through analyzing an individual’s genetic composition, personal genome services facilitate personalized medicine by forecasting disease risk, assisting in drug choice, and customizing prevention and treatment approaches. An example demonstrating this trend is that in February 2024, the Personalized Medicine Coalition, a US-based non-profit, reported that the FDA sanctioned 16 novel personalized treatments for patients with rare diseases in 2023, an increase from six in 2022. The personalized treatments given approval in 2023 further comprised seven medications for cancer and three for other health conditions. Consequently, the heightened attention on personalized medicine is serving as a catalyst for the expansion of the personal genome services market.

How Is The Personal Genome Services Market Categorized Across Its Segment Groups?

The personal genome services market covered in this report is segmented –

1) By Service Type: Genetic Testing; Whole Genome Sequencing; Carrier Testing; Ancestry Testing; Other Service Types

2) By Application: Healthcare; Research; Ancestry; Other Applications

3) By End-User: Hospitals and Clinics; Research Centers; Direct-to-Consumer; Other End-Users

Subsegments:

1) By Genetic Testing: Health Risk Assessment Testing; Pharmacogenomic Testing; Nutritional Genetic Testing; Lifestyle Genetic Testing; Wellness Genetic Screening

2) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; Preventive Health Genome Sequencing; Rare Disease Genome Sequencing; Population Based Genome Sequencing

3) By Carrier Testing: Inherited Disease Carrier Screening; Preconception Carrier Testing; Prenatal Carrier Testing; Reproductive Health Carrier Screening; Family Planning Carrier Testing

4) By Ancestry Testing: Ethnicity Estimation Testing; Genealogical Lineage Testing; Migration Pattern Analysis; Regional Ancestry Breakdown; Family Relationship Discovery

5) By Other Service Types: Newborn Genetic Screening; Predictive Genetic Testing; Sports Performance Genetic Analysis; Personalized Health Reporting; Custom Genetic Consulting Services

What Emerging Trends Are Seen In The Personal Genome Services Market?

Major companies engaged in the personal genome services market are concentrating on developing advanced solutions, including genome-wide risk stratification, to deliver personalized health insights, predict susceptibility to diseases, and guide both preventive and lifestyle interventions. Genome-wide risk stratification is defined as the process of analyzing an individual’s entire genome to identify genetic variations contributing to the risk of developing specific diseases or conditions, thereby enabling tailored predictions of health risks and targeted preventive strategies. For example, in November 2025, MyOme Inc., a US-based biotechnology company, launched the first integrated polygenic risk score (iPRS) test for prostate cancer. This test combines approximately 7 million genetic markers with clinical factors to provide personalized 10-year and lifetime risk estimates, which have been validated in over 140,000 diverse men. Its objective is early detection and prevention for 95% of cases without rare variants such as BRCA2, directing PSA or MRI or biopsies for high-risk individuals (those in the top decile having 3-4x elevated odds) while simultaneously reducing false positives and overtreatment. The benefits encompass precise stratification, equitable performance across various ancestries, and lifelong AI-updated insights from a single whole-genome sample.

Which Firms Are Influencing Competition In The Personal Genome Services Market?

Major companies operating in the personal genome services market are Thermo Fisher Scientific Inc, Illumina Inc, Helix OpCo LLC, Ancestry.com Operations Inc, Fulgent Genetics Inc, 23andMe Holding Co, Prenetics Global Limited, MyHeritage Ltd, Color Health Inc, Genomics plc, GenoPalate Inc, Living DNA Ltd, Mapmygenome India Pvt Ltd, Nebula Genomics Inc, Xcode Life Sciences Pvt Ltd, Sema4 Holdings Corp, Gene by Gene Ltd, TellmeGen SL, CRI Genetics LLC, African Ancestry Inc, and DNAFit Limited.

Get The Full Personal Genome Services Market Report:

https://www.thebusinessresearchcompany.com/report/personal-genome-services-market-report

Which Geographic Region Dominates The Personal Genome Services Market?

North America was the largest region in the personal genome services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personal genome services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Personal Genome Services Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/customise?id=33258&type=smp

Browse Through More Reports Similar to the Global Personal Genome Services Market 2026, By The Business Research Company

Genomics Services Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-services-global-market-report

Genomics Personalized Health Market Report 2026

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Consumer Genomics Market Report 2026

https://www.thebusinessresearchcompany.com/report/consumer-genomics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795